or Try an Advanced Search...

    Technical Analysis for PSNL - Personalis, Inc.

    Grade Last Price % Change Price Change
    F 1.25 -3.85% -0.05
    PSNL closed down 3.85 percent on Thursday, April 25, 2024, on 46 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
    Earnings due: May 1
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PSNL trend table...
    Date Alert Name Type % Chg
    Hammer Candlestick Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Fell Below 20 DMA Bearish -3.85%
    Bollinger Band Squeeze Range Contraction -3.85%
    Inside Day Range Contraction -3.85%
    Crossed Above 20 DMA Bullish -9.42%
    MACD Bullish Signal Line Cross Bullish -9.42%
    Bollinger Band Squeeze Range Contraction -9.42%
    Spinning Top Other -0.79%
    Bollinger Band Squeeze Range Contraction -0.79%
    Older End-of-Day Signals for PSNL ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR about 17 hours ago
    Down 5% about 18 hours ago
    Down 3% about 18 hours ago
    Fell Below Previous Day's Low about 18 hours ago
    Down 2 % about 18 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    PSNL Chart by TradingView
    Basic chart:

    Profile

    Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves approximately 45 biopharmaceutical customers, including a range of pharmaceutical companies. The company was founded in 2011 and is headquartered in Menlo Park, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Biology Telehealth Telemedicine Genomics Medical Genetics Molecular Diagnostics Applied Genetics Cancer Therapies Analysis Services Biopsy Data Analysis Services Cancer Therapy Oncogenomics Treating Cancer

    Is PSNL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 24 Personalis to Announce First Quarter 2024 Financial Results
    Apr 17 Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
    Apr 4 Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor
    Mar 29 Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
    Mar 28 Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
    Mar 28 Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    Mar 26 Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
    Mar 20 Cathie Wood's Ark Invest Isn't Done Selling Shares Of Jack Dorsey-Led Block Yet — Sheds $7.5M Worth of Stock As Bitcoin Price Drops
    Mar 19 Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Feb 29 Personalis, Inc. (NASDAQ:PSNL) Q4 2023 Earnings Call Transcript
    See more PSNL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.59
    52 Week Low 0.8912
    Average Volume 322,971
    200-Day Moving Average 1.51
    50-Day Moving Average 1.44
    20-Day Moving Average 1.34
    10-Day Moving Average 1.27
    Average True Range 0.10
    RSI (14) 41.86
    ADX 17.3
    +DI 19.43
    -DI 25.05
    Chandelier Exit (Long, 3 ATRs) 1.23
    Chandelier Exit (Short, 3 ATRs) 1.49
    Upper Bollinger Bands 1.50
    Lower Bollinger Band 1.17
    Percent B (%b) 0.24
    BandWidth 24.53
    MACD Line -0.06
    MACD Signal Line -0.06
    MACD Histogram 0.0019
    Fundamentals Value
    Market Cap 61.29 Million
    Num Shares 49 Million
    EPS -2.38
    Price-to-Earnings (P/E) Ratio -0.53
    Price-to-Sales 0.83
    Price-to-Book 0.39
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.40
    Resistance 3 (R3) 1.39 1.34 1.38
    Resistance 2 (R2) 1.34 1.30 1.34 1.37
    Resistance 1 (R1) 1.29 1.27 1.27 1.30 1.36
    Pivot Point 1.24 1.24 1.22 1.24 1.24
    Support 1 (S1) 1.19 1.20 1.17 1.20 1.14
    Support 2 (S2) 1.14 1.17 1.14 1.13
    Support 3 (S3) 1.09 1.14 1.13
    Support 4 (S4) 1.10